Checkpoint, cytotoxicity, and TRM signature scores, as well as ENTPD1 expression, were also higher in pTRC from the tumor, and stemness scores were lower in tumor pTRC (Fig. 5C–F; Supplementary Fig. 10C–D). This evidence concerns the gene ENTPD1 and neoplasm.